Women's Health: Market for Minimally Invasive Female Urinary Incontinence Devices December 2016

This report focuses on minimally invasive therapy systems designed for the treatment of female urinary incontinence (UI); market segments covered include injectable urethral bulking agents, urethral sling systems, and neuromodulation systems. Female UI is an attractive market to medical device companies and investors, and will continue to be in the long-term. The incidence and prevalence of UI is increasing as the population ages and diabetes and obesity rates climb.